483 Biogen Apr 2017

483 Biogen Apr 2017

Richard Abate FDA, Erik Koester FDA, John Mistler FDA$119.00 - Available Now

FDA investigators audited the Biogen - Cambridge, MA, United States facility and issued inspectional observations (via FDA 483) on 06 Apr 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 06 Apr 2017
  • Location: Cambridge, United States
  • FEI: 1220951
Add To Cart